-
Abbott launches new initiative to drive diversity in medical research and improve care among under-represented populations
WorldPharmaNews
November 04, 2021
Abbott (NYSE: ABT) today announced the launch of a new initiative designed to help create a more inclusive clinical trial ecosystem through new approaches to training, education, and improving the clinical research
-
UK releases implementation plan for developing clinical research delivery
europeanpharmaceuticalreview
June 24, 2021
The new implementation plan lays out the steps the UK Government and clinical research community will take to improve research and tackle health inequalities.
-
COVID-19 Clinical Research Coalition to accelerate coronavirus R&D in resource-poor countries
europeanpharmaceuticalreview
April 07, 2020
The coalition has been formed to find R&D solutions for low- and middle-income countries to limit the impact of the COVID-19 pandemic in areas with fragile healthcare systems.
-
Sihuan Pharmaceutical Announces Clinical Research of Favipiravir, Co-Developed with the Academy of Military Medical Sciences of the People's Liberation Army, Has Commenced
prnasia
March 02, 2020
The Trials was officially initiated by the Ministry of Science and Technology in early February. The Human Genetic Resources Management Office of the PRC urgently reviewed the Trials and the Group obtained the human genetic resources administrative licens
-
KEYTRUDA, Chemotherapy Combination Met Primary Endpoint
americanpharmaceuticalreview
July 30, 2019
Merck announced the Phase 3 KEYNOTE-522 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy met one of the dual-primary endpoints of pathological complete response (pCR) following the neoadjuvant part of ...
-
NMPA Issued the Announcement on Issues Concerning the Import of Reference Drugs for Clinical Research of Biosimilar Drugs
chinadaily
July 23, 2019
On November 30, 2018, NMPA issued the Announcement on Issues Pertaining to the One-off Import of Reference Drugs for Biologicals in Clinical Trials (Announcement No. 94 of 2018), clarifying that the applicant can apply for ...
-
Amgen, Novartis, Banner Alzheimer's Institute Discontinue CNP520 Clinical Research
americanpharmaceuticalreview
July 16, 2019
Amgen, Novartis, and Banner Alzheimer's Institute announced the collective decision to discontinue investigation of the BACE1 inhibitor CNP520 (umibecestat) in ...
-
MEDI FUTURES signs MOU with SUHB for clinical research
biospectrumasia
May 06, 2019
Clinical research to be conducted on ultrasound-based adipose stem cell separation technology and 3D sutures
-
Evolution Research Acquires Finger Lakes Clinical Research
contractpharma
April 02, 2019
Specializes in pediatric and adult central nervous system trials for major national and international pharmaceutical firms
-
Pfizer Study Finds Progress in Combating Fatty Liver
firstwordpharma
March 28, 2019
Pfizer unveiled mid-stage study results illustrating that a drug that prevents the body from metabolising fructose significantly reduced liver fat, Bloomberg reported Wednesday.